Safety of canagliflozin in diabetic patients with chronic heart failure: randomized, non-inferiority trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Canagliflozin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms CANDLE
- 27 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Nov 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
- 28 May 2015 New trial record